Hoffmann-La Roche, say the new antibiotic, zosurabalpin, can effectively kill Acinetobacter baumannii.
Zosurabalpin is in its own chemical class and has a unique method of action, says Dr. Kenneth Bradley, the global head of infectious disease discovery with Roche Pharma Research and Early Development and one of the researchers.